Make your money go further for just 25p per day

Robinson plc (AIM:RBN) – results ok, outlook cautionary, valuation attractive?

27/03/2015 · Robinson plc (RBN) 

The custom manufacturer of plastic and paperboard packaging based announced results for the year ended 31 December 2014 marginally ahead of broker estimates. With decent cash flow and strong asset backing the shares are surely worth a look at current levels!

We first covered Robinson back in February 2012 

Headquartered in Chesterfield, with manufacturing facilities in Kirkby-in-Ashfield, Stanton Hill (Nottinghamshire) and Lodz and Warsaw (Poland), Robinson currently employs around 310 people. It was formerly a family business, with its origins dating back some 176 years. Today the Group’s main activity is the manufacture and sale of injection moulded plastic packaging. Robinson operates primarily within the food, drink, confectionery, cosmetic and toiletry sectors, providing niche…

Sign up and read the full article

Register to continue reading our content.

Get FREE access now

Already a member? Login


Previous article Next article

DON'T MISS OUT!

Get top investment ideas to help safeguard and grow your wealth.

Invaluable insight from the exciting world of smaller companies.

REGISTER FREE

DON'T MISS OUT ON OUR PREMIUM CONTENT

Become a champion investor for just £90 a year. Benefit from our high performing portfolios:

START FREE TRIAL

More on Robinson plc

Robinson plc (AIM:RBN) – results ok, outlook cautionary, valuation attractive?

27/03/2015 · Company Insights
The custom manufacturer of plastic and paperboard packaging based announced results for the year ended 31…

Blue chip client base and significant property backing

16/02/2012 · Company Insights
The AIM quoted custom manufacturer of plastic and paperboard packaging has been around for over 150…

More Company Insights

Bonkers Bargains: another great update

18/07/2024 · Alumasc Group PLC

Chain cheers | Interest winner | Meaty first

17/07/2024 · Agronomics · Gateley · Renold · Team17

Big growth in human challenge trials

17/07/2024

Sign-up to our free email updates

SIGN UP